While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to continue.
Investor's Business Daily on MSN
Four biotech stocks near buy points as earnings season kicks in
Four biotech stocks in the IBD 50 are in bases as first-quarter earnings rolls in. Travere Therepeutics is below a buy point ...
Mirum's stock could skyrocket if those clinical results are positive. Some things are inherently risky. Feeding a bear while ...
In this article, we will be taking a look at the 10 Best Biotech Stocks Under $10 to Buy. According to Eli Casdin, CEO of ...
These companies boast significant upside potential.
Kailera Therapeutics appears to have set a new benchmark for biotech IPOs with an upsized $625 million offering to fund its ...
In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector's two major indexes - the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) - ...
Continue » Viking is a biotech company specializing in metabolic diseases. The company hasn't yet commercialized a drug, but ...
The high-profile obesity drug developer priced the biotech sector’s biggest offering in years and will use the proceeds to ...
Granted, revenue has still been higher over the past few years than it was before COVID-19, but the stock price is also down ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results